In human HCC, patients with higher TREM2 IHC scores had a greater recurrence ratio compared to those with lower TREM2 IHC scores (55.9% vs. 32.4%; Supplementary Fig. 5B). Here, TREM2 is linked to hepatocellular carcinoma.